MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Neurotech Welcomes Industry Veteran Beth Marsh as Chief Commercial Officer

Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

11 Dec 2025

Medra, the company developing the first platform for Physical AI Scientists, announced a $52...

European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

Align Technology Supports Children and Teens With 30 Invisalign® Treatments via Smiles4Canada Program

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

By Medella Springs
Medella Springs
02 Jun 2026

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

By Seegene
Seegene
02 Jun 2026

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

By Ascensia Diabetes Care
Ascensia Diabetes Care
02 Jun 2026

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

By Shionogi USA
Shionogi USA
01 Jun 2026

EU Approves Expanded Label for Opdivo® + AVD in Advanced Hodgkin Lymphoma

By Bristol Myers Squibb
Bristol Myers Squibb
01 Jun 2026

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

By Foundation Medicine
Foundation Medicine
01 Jun 2026

The Digital Pharma Advances Conference 2026

Most Popular

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

By Merck & Co., Inc.

Oct 28
AdvanCell Proudly Announces $18M in MRFF Frontiers Initiative Funding to Advance Targeted Alpha Therapy for Defeating Prostate Cancer

By AdvanCell

Apr 14
Cellenkos, Inc. receives FDA clearance to begin Phase 2 trial of CK0801 (allogeneic cord blood-derived Tregs) for aplastic anemia

By Cellenkos, Inc.

Apr 27

June 2026

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Neurotech Welcomes Industry Veteran Beth Marsh as Chief Commercial Officer

Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

Align Technology Supports Children and Teens With 30 Invisalign® Treatments via Smiles4Canada Program

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

EU Approves Expanded Label for Opdivo® + AVD in Advanced Hodgkin Lymphoma

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

Most Popular

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

AdvanCell Proudly Announces $18M in MRFF Frontiers Initiative Funding to Advance Targeted Alpha Therapy for Defeating Prostate Cancer

Cellenkos, Inc. receives FDA clearance to begin Phase 2 trial of CK0801 (allogeneic cord blood-derived Tregs) for aplastic anemia

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter